Skip to main content
. 2024 Nov 26;65(13):56. doi: 10.1167/iovs.65.13.56

Figure 7.

Figure 7.

Proposed pathophysiology of the loss of activity of bevacizumab solutions as a consequence of aggregation through polysorbate deprivation.